Longer-Term Efficacy and Safety of Evinacumab in Patients With Refractory Hypercholesterolemia

IMPORTANCE: Patients with refractory hypercholesterolemia who do not achieve their guideline-defined low-density lipoprotein cholesterol (LDL-C) thresholds despite treatment with maximally tolerated combinations of lipid-lowering therapies (LLTs) have an increased risk of atherosclerotic cardiovascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenson, Robert S., Burgess, Lesley J., Ebenbichler, Christoph F., Baum, Seth J., Stroes, Erik S. G., Ali, Shazia, Khilla, Nagwa, McGinniss, Jennifer, Gaudet, Daniel, Pordy, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500429/
https://www.ncbi.nlm.nih.gov/pubmed/37703006
http://dx.doi.org/10.1001/jamacardio.2023.2921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500429/
https://www.ncbi.nlm.nih.gov/pubmed/37703006
http://dx.doi.org/10.1001/jamacardio.2023.2921

Ejemplares similares